BioGеNext Conference

BioGеNext Conference BioGENext is an international initiative fostering the development of next-generation science, biotechnology, and biomedicine.

Strong research is only part of the journey. Its value also depends on how clearly the evidence and practical relevance ...
25/08/2026

Strong research is only part of the journey. Its value also depends on how clearly the evidence and practical relevance can be communicated, and whether scientific results can translate into solutions that are understood, evaluated, and applied. At BioGENext Conference 2026, this is not a secondary concern, it is the main focus. This transition directly reflects Apixmed's own experience.

Therefore, we are glad to welcome Apixmed as a new partner of the BioGENext Project Pitching Competition 2026.

Maryna Korshevniuk, Co-founder and CEO of Apixmed, will join BioGENext as a mentor. Maryna will help participants prepare for BioGENext Pitching Day by sharpening the value of their developments, structure their arguments, and communicate complex science clearly and convincingly — helping strong research translate into a compelling technological story without oversimplifying the science.

Apixmed will also offer a special prize for one participant: Apixmed Prism (the full Ultima genetic panel).

Why supporting BioGENext matters to Apixmed.
Apixmed builds technology designed not merely to generate genetic results, but to bring different layers of biomedical information into a holistic picture — and enable meaningful work with that information. What matters is not only new data, but the quality of its interpretation, the context, and the ability to turn knowledge into practical solutions.

BioGENext creates an environment where researchers, startups, technology companies, and experts can come together at the stage when a strong scientific idea needs to find its form, its argumentation, partners, and a path for further development. Apixmed joins not only as a partner, but as a participant in this process. Through project mentoring, Apixmed aims to share its experience at the intersection of science, bioinformatics, product development, and the communication of complex biomedical solutions — helping teams present their developments more effectively and demonstrate their potential practical value more clearly.

BioGENext Conference 2026 · October 6–9 · Kyiv
Register for the conference: https://biogenext.org/

Research projects often require more than individual instruments — they need solutions designed around specific scientif...
31/07/2026

Research projects often require more than individual instruments — they need solutions designed around specific scientific tasks, supported by technical expertise and reliable infrastructure.

One of our competition partners and award sponsors is HLR (Хімлаборреактив) — a Ukrainian company with 30 years of experience in providing integrated solutions for laboratories and the scientific community.

Rather than simply supplying laboratory equipment, HLR develops tailored solutions based on the specific needs of each project. The company brings together a team of 450+ technical specialists, equipment from leading global manufacturers, ISO 9001 certification, a 22,000 m² warehouse infrastructure, and 24/7 service support.

Why supporting BioGENext matters to HLR:
“Supporting BioGENext 2026 is our contribution to the future of Ukrainian science and biotechnology. We believe that supporting young researchers, innovative projects, and professional collaboration helps build a strong scientific ecosystem and creates conditions in which promising ideas can develop into practical technologies and solutions. For HLR, it is important to be part of this community, support talented researchers, and help create an environment where promising ideas can grow into real technologies and scientific achievements.”

As a partner of the BioGENext Project Pitching Competition 2026, HLR will support one of the winning projects with research resources that can be used to obtain laboratory equipment or other products relevant to the project from the company’s portfolio.

We are very glad to have HLR as a BioGENext partner and to work together in supporting Ukrainian researchers and creating new opportunities for promising scientific project.

Turning a research idea into an experiment requires access not only to instrumentation and reagents, but also to the exp...
31/07/2026

Turning a research idea into an experiment requires access not only to instrumentation and reagents, but also to the expertise needed to build the right workflow.

One of our competition partners and award sponsors is АЛТ Україна — a Ukrainian company that has been providing advanced solutions for laboratories, hospitals, and research institutions since 2008.

The company works across cell and molecular biology, molecular diagnostics, cell therapy, microscopy, chromatography, spectroscopy, and laboratory technologies, providing comprehensive technical, service, and application support.

As an official partner of Thermo Fisher Scientific, ALT Ukraine combines its own application expertise with access to global scientific and technological solutions — from instrumentation and workflow development to reagents, consumables, and methodological support.

Why supporting this competition matters to ALT Ukraine:
“Together with Thermo Fisher Scientific, we are deeply committed to supporting the scientific community in Ukraine, and especially its youngest members. The future of Ukrainian science and healthcare depends on the people we invest in today. By giving students and early-career researchers access to world-class technologies, we help them ask bolder questions and turn their ambitions into real discoveries.”

For the winner of the BioGENext Project Pitching Competition 2026, ALT Ukraine offers access to its broad portfolio of technologies — from cell therapy and advanced cell biology to molecular diagnostics, cell culture, and next-generation sequencing (NGS). 🧬 If the winning project is based on NGS, the ALT Ukraine team will sequence the project libraries free of charge, providing additional support for the implementation of the research.

Behind every research project are not only ideas and people, but also access to the technologies and tools needed to tes...
31/07/2026

Behind every research project are not only ideas and people, but also access to the technologies and tools needed to test those ideas in practice. That is why an important part of the BioGENext Project Pitching Competition is collaboration with companies that work directly with the scientific community.

One of our competition partners and award sponsors is BioLabTech — a Ukrainian company with nearly 20 years of experience in integrated laboratory solutions and strong expertise in Next-Generation Sequencing (NGS) technologies.

Biolabtech works across genomics, molecular diagnostics, cell technologies, and laboratory infrastructure, combining technologies from leading global manufacturers with end-to-end project support — from technology selection and implementation to technical service and after-sales support.

Through its partnership with the BioGENext Project Pitching Competition 2026, BioLabTech supports promising research projects and helps expand access to modern technologies for Ukrainian researchers.

Why supporting this competition matters to BioLabTech:
“Through our support of the BioGENext Project Competition, we aim to foster the development of promising scientific projects, expand access to advanced technologies, and strengthen Ukraine’s scientific community.”

We are glad to have BioLabTech among the partners helping us create practical opportunities for researchers within BioGENext 2026.

Prof. Dr. Ivan Gout is a group leader in the Structural & Molecular Biology Department at University College London, UK....
27/07/2026

Prof. Dr. Ivan Gout is a group leader in the Structural & Molecular Biology Department at University College London, UK. He earned his MD from Lviv State Medical University (Ukraine) in 1983, then pursued a career in oncology, completing a PhD at the Institute of Experimental Oncology, National Academy of Sciences of Ukraine, in 1987. He moved to the UK for postdoctoral training and subsequently established his own laboratory at the Ludwig Institute for Cancer Research, where he began investigating the regulation of cell growth and metabolism in health and disease with a particular focus on coenzyme A (CoA) biology.

CoA is an essential metabolic cofactor found in all living cells. It functions primarily as a carrier of acyl groups, most notably in the form of acetyl-CoA, enabling reactions such as the Krebs cycle, fatty acid oxidation and synthesis, and the biosynthesis of various other biomolecules. In humans, dysregulation of CoA biosynthesis, caused by inborn mutations in the core CoA biosynthetic pathway (such as in PANK2 and CoASy), directly causes severe, rare neurodegenerative and neurodevelopmental disorders.

Beyond this well-established metabolic role, the Gout group recently discovered a previously unanticipated antioxidant function of CoA, along with a novel post-translational modification termed protein CoAlation – a form of S-thiolation in which, under oxidative or metabolic stress, CoA covalently binds to exposed cysteine residues on cellular proteins. This modification acts as a crucial shield, protecting vital proteins from irreversible oxidative damage. The majority of CoAlated proteins identified are involved in metabolic processes, antioxidant stress responses, and protein synthesis, and CoAlation has been shown to modulate the activity and subcellular localization of its target proteins.

Based on these findings, the Gout group proposes a dual role for CoA: functioning as a key metabolic cofactor under physiological conditions, while acting as an antioxidant in the cellular response to oxidative or metabolic stress. This discovery and related subsequent findings have established the Gout Lab as a world-leading laboratory in the study of protein CoAlation and the antioxidant function of CoA.

We are thrilled to announce that Dr. Gout will join us at the BioGENext Conference 2026, delivering a lecture on "Coenzyme A Biology in Health and Disease". To help you get primed for this insightful presentation, we're sharing a list of topic-related papers below:
1.Gout I. Coenzyme A, protein CoAlation and redox regulation in mammalian cells. Biochem Soc Trans. 2018 Jun 19;46(3):721-728. doi: 10.1042/BST20170506
2. Filonenko V, Gout I. Discovery and functional characterisation of protein CoAlation and the antioxidant function of coenzyme A. BBA Adv. 2023 Jan 13;3:100075. doi: 10.1016/j.bbadva.2023.100075
3. Zhang D, Brett C, Cho J, Lashley T, Gout I. Coenzyme A in Brain Biology and Neurodegeneration. Biomedicines. 2025 Dec 29;14(1):69. doi: 10.3390/biomedicines14010069

Great news for the BioGENext community! Participation in BioGENext Conference 2026 is now completely FREE.Thanks to the ...
17/07/2026

Great news for the BioGENext community! Participation in BioGENext Conference 2026 is now completely FREE.

Thanks to the incredible support of our partners, the registration fee for BioGENext Conference 2026 has been completely waived for all participants.
This means that everyone interested in biotechnology, molecular biology, biomedicine, genomics, diagnostics, and related fields can now join the conference free of charge. We remain committed to delivering the same high-quality scientific program, highly relevant topics and the highest organizational standard.

In addition, all hands-on workshops provided by our partners will also be free of charge (subject to prior registration).

Travel grants are also available! Thanks to our partners, we have also preserved travel grants for participants from other cities in Ukraine. We will shortly send invitation letters and conditions of participation to apply for this opportunity to everyone who has submitted abstracts for the poster session and Flash Talks.

All registration fees already paid will be fully refunded. Our team will contact those participants who have already paid to coordinate the details.

Today, as Ukrainian science operates under exceptionally challenging conditions, it is deeply important to us to support our scientific community and create opportunities for development, collaboration, and new ideas.
We express our sincere gratitude to our partners for this opportunity to support local researchers during these difficult times. We hope this decision will allow even more researchers, students, and innovators to become part of BioGENext 2026.

Register and join the BioGENext Conference 2026 community: https://biogenext.org/
We can't wait to welcome you to BioGENext Conference 2026!

Applications are now open for the BioGENext Project Pitching Competition 2026!This is your chance to present your resear...
19/06/2026

Applications are now open for the BioGENext Project Pitching Competition 2026!
This is your chance to present your research at BioGENext Conference 2026 and compete for research awards that can help fund an important stage of your project

The BioGENext Pitching Day offers a valuable platform to increase the visibility of your work, receive expert feedback, and build connections that may lead to future scientific or industry collaborations.

Three winning projects will each receive research support equivalent to $5,000 USD (in UAH) for purchasing reagents or laboratory equipment from our sponsor-partners.
We are proud to launch this initiative together with our partners: Biolabtech, АЛТ Україна, Хімлаборреактив

Key dates
• Application deadline — August 1, 2026
• Scientific evaluation — September 2026
• Project pitching will take place live during BioGENext Conference 2026 in Kyiv.

More information and application form: https://event.fourwaves.com/biogenextconference/pages/897d0a4c-0c29-4f6c-8ac8-e3f881770f15

We look forward to discovering bold ideas that will shape the future of biomedical research in Ukraine.

We would like to kindly remind you that the Early Bird abstract submission deadline for the BioGENext Conference 2026 is...
31/05/2026

We would like to kindly remind you that the Early Bird abstract submission deadline for the BioGENext Conference 2026 is May 31, 2026.

Abstract submission before this date is free of charge. Accepted abstracts will be reviewed by the Scientific Committee and selected for publication in the open-access, peer-reviewed international journal “Biopolymers and Cell”.

📌 Abstract guidelines: https://event.fourwaves.com/biogenextconference/pages/b62c4875-2e6f-49d8-bb1c-f3cb453622d3

📌 Abstract template/example:https://cdn.fourwaves.com/static/media/filecontent/e81a2892-ef73-408b-9895-290526818e8c/be654f42-dc63-42e6-8256-19a6a2f0b7fa.pdf

📌 Submit your abstract: https://event.fourwaves.com/biogenextconference/submission

We warmly invite researchers, young scientists, PhD students, students, and industry representatives to join BioGENext Conference 2026 and present their scientific achievements to the international community.

We look forward to your submissions!

We are happy to announce that Bjørn Voldborg, Head of the National Biologics Facility at Technical University of Denmark...
29/05/2026

We are happy to announce that Bjørn Voldborg, Head of the National Biologics Facility at Technical University of Denmark has accepted the invitation to become a speaker at the BioGENext Conference 2026! His talk, "CHO-sen by Design: Cell Line Engineering for Biologics Production", will cover a decade of his work at DTU in engineering CHO cell lines into superior biopharmaceutical production platforms.

Bjørn Voldborg (Head of the National Biologics Facility, Technical University of Denmark (DTU)) is a leading international expert in biopharmaceutical manufacturing, mammalian cell line engineering, and recombinant protein production. From January 2024, he serves as a Senior Advisor in Mammalian Cell Technologies at Bioneer A/S, a non-profit CRO. Over the past 25+ years, he has been working on strengthening the bridge between industrial biomanufacturing and academic synthetic biology. His work heavily emphasizes the development of optimized host systems for therapeutics, i.e., monoclonal antibodies and glycoproteins.

In biotechnology, "cell factories" are reprogrammed via synthetic biology and metabolic engineering to produce therapeutics. They act as tiny manufacturing units consuming renewable resources to eventually generate biochemicals, pharmaceuticals, etc. Voldborg is widely recognized for his work with Chinese Hamster O***y (CHO) cells, known as the industry workhorse for producing various complex therapeutic proteins.

His research group has pioneered methods designed to engineer CHO cells into highly efficient, predictable, and controlled cellular factories. Another significant portion of Bjørn Voldborg's research is dedicated to tailoring the post-translational modifications of recombinant proteins. By manipulating the glycosylation pathways of mammalian cells, his work aims to improve the biochemical properties, serum half-life, bioactivity, and immunogenicity of complex glycoproteins (such as the hepatitis C virus E2 glycoprotein or therapeutic cytokines like GM-CSF).

Below, you can find key papers related to the topic:
1. Kotidis P, Donini R, Arnsdorf J, Hansen AH, Voldborg BGR, Chiang AWT, Haslam SM, Betenbaugh M, Jimenez Del Val I, Lewis NE, Krambeck F, Kontoravdi C. CHOGlycoNET: Comprehensive glycosylation reaction network for CHO cells. Metab Eng. 2023 Mar;76:87-96. doi: 10.1016/j.ymben.2022.12.009. Epub 2023 Jan 4. PMID: 36610518; PMCID: PMC11132536.
2. Kol, S., Ley, D., Wulff, T... Voldborg, B.G. ... et al. Multiplex secretome engineering enhances recombinant protein production and purity. Nat Commun 11, 1908 (2020). https://doi.org/10.1038/s41467-020-15866-w

Don't miss the opportunity to connect with world-renowned experts in biotechnology and biomedicine!
Register now: https://biogenext

Address

Kyiv

Website

Alerts

Be the first to know and let us send you an email when BioGеNext Conference posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to BioGеNext Conference:

Shortcuts

Share

Category